help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on April 17, 2008, doi:10.1164/rccm.200711-1637OC

Am. J. Respir. Crit. Care Med., Volume 178, Number 1, July 2008, 26-33

A more recent version of this article appeared on July 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200711-1637OCv1
178/1/26    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bateman, S. T
Right arrow Articles by Randolph, A. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bateman, S. T
Right arrow Articles by Randolph, A. G

Submitted on November 6, 2007
Accepted on April 17, 2008

Anemia, Blood Loss, and Blood Transfusions in North American Children in the Intensive Care Unit

Scot T Bateman1*, Jacques Lacroix2, Katia Boven3, Peter Forbes4, Roger Barton5, Neal J Thomas6, Brian Jacobs7, Barry Markovitz8, Brahm Goldstein9, James H Hanson10, H. Agnes Li3, and Adrienne G Randolph4

1 University of Massachusetts Medical Center, Worcester, MA, USA, 2 CHU Sainte-Justine, Montreal, PQ, Canada, 3 Research and Development, Johnson and Johnson Pharmaceutical, Raritan, NJ, USA, 4 Children's Hospital, Boston, MA, USA, 5 Children's Hospital of Saint Francis, Tulsa, OK, USA, 6 Penn State Children's Hospital, Hershey, PA, USA, 7 Children's National Medical Center, Washington, DC, USA, 8 Childrens Hospital of Los Angeles, Los Angeles, CA, USA, 9 Novo Nordisk Inc., Princeton, NJ, USA, 10 Children's Hospital and Research Center Oakland, Oakland, CA, USA

* To whom correspondence should be addressed. E-mail: batemans{at}ummhc.org.

Rationale: Minimizing exposure of children to blood products is desirable. Objective: We aimed to understand anemia development, blood loss, and red blood cell (RBC) transfusions in the Pediatric Intensive Care Unit (PICU). Methods: Prospective, multi-center, 6 month observational study in 30 PICUs. Data were collected on consecutive children (<18 years old) in the PICU ≥ 48 hours. Measurements: Anemia development, blood loss, and RBC transfusions. Main Results: 977 children were enrolled. Most (74%) children were anemic in the PICU (33% on admission, 41% developed anemia). Blood draws accounted for 73% of daily blood loss; median loss was 5.0 ml/day. 49% of children were transfused; 74% of 1st transfusions were on days 1-2. After adjusting for age and illness severity, compared to non-transfused children, transfused children had significantly longer days of mechanical ventilation (2.1 days (p<0.001)) and PICU stay (1.8 days (p=0.03)), and had increased mortality (OR 11.6, 95% CI 1.43-90.9, p=0.02), nosocomial infections (OR 1.9, 95% CI 1.2-3.0, p=0.004), and cardio-respiratory dysfunction (OR 2.1, 95% CI 1.5- 3.0 p<0.001). High blood loss/kg from blood draws (OR 1.11, 95%CI 1.03-1.2, p=0.01) was associated with RBC transfusion >48 hours after admission. The most common indication for transfusion was low hemoglobin (42%). Pre-transfusion hemoglobin values varied greatly (mean 9.7 ± 2.7 g/dL). Conclusions: Critically ill children are at significant risk for developing anemia and receiving blood transfusions. Transfusion in the PICU was associated with worse outcomes. It is imperative to minimize blood loss from blood draws and to set clear transfusion thresholds.


Key words: blood loss, anemia, transfusions, pediatric, intensive care







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society
  ATS State of the Art 2009